Synaptogenix Inc (SNPX)

[Whatsupp]

"There is no way an IV drug that has to be used twice a month will gain significant traction in the mild to moderate group if Anavex is successful."

First they are targeting the mod to severe group initially, so not a problem. It also means they do not have to data mine patients in order to run a phase 3 trial like Avxl.

Second, long before 2-73 does a Phsse 3, there will be a bryoststin pill.